Real-time PCR data revealed that SGSM2 mRNA was more highly expressed in ER-positive malignant tissues than in ER-negative tissues from 200 BC patients, and its protein expression was also associated with ER-positive BC cells. This evidence concerns the gene SGSM2 and breast cancer.